05/28/2026
When longevity medicine arrives at scale, it will depend as much on logistics as on biology. That's the throughline of a new Longevity.Technology feature on Ossium and a conversation with our Co-Founder & CEO Kevin Caldwell.
Bone marrow transplantation has been quietly extraordinary for decades: a procedure that rebuilds a patient's entire blood and immune system from donor-derived stem cells. But it has remained dependent on living donors, narrow collection windows, and choreography that often breaks when disease moves faster than the donor coordination.
Ossium is building the alternative: a cryopreserved bank of organ donor-derived bone marrow, processed and characterized for on-demand use.
The near-term goal is access. The longer-term implication, as the piece explores, is harder to ignore: if hematopoietic stem cells sit at the root of immune decline, the infrastructure for transplantation may also be infrastructure for immune renewal.
đź”—
As immunosenescence drives systemic disease, banked bone marrow could scale from a transplant tool into healthspan infrastructure.